Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
Acute T Cell Lymphoblastic LeukemiaHaploidentical Hematopoietic Stem Cell TransplantationCord Blood
Interventions
BIOLOGICAL

Haplo-cord HCT

Haploidentical hematopoietic cell transplantation will be performed with coinfusion of an unrelated cord blood unit

BIOLOGICAL

Haplo-HCT

Hematopoietic cell transplantation will be performed with a haploidentical donor

Trial Locations (1)

215000

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
collaborator

Children's Hospital of Soochow University

OTHER

collaborator

Ruijin Hospital

OTHER

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Fujian Medical University Union Hospital

OTHER

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

Zhejiang University

OTHER

lead

The First Affiliated Hospital of Soochow University

OTHER